Filing Flows › BioAge Labs (BIOA) › Q2 2026 › vs Q2 2025
BioAge Labs (BIOA) Q2 2026 vs Q2 2025 (year over year)
BioAge Labs's revenue rose $39K (+2%) from $2.4M in Q2 2025 to $2.5M in Q2 2026.
BioAge Labs, Q2 2026: revenue $2.5M (+2% year over year), net loss $26.1M, operating cash flow −$19.3M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.5M | $2.4M | $39K | +2% |
| Other income, net | $3.2M | $3.2M | $28K | +0.9% |
| Net loss | $26.1M | $21.6M | $4.5M | +21% |
| Costs & expenses | $31.8M | $27.2M | $4.6M | +17% |
| Operating costs | $31.8M | $27.2M | $4.6M | +17% |
| Research & development | $24.4M | $19.8M | $4.5M | +23% |
| General & admin | $7.4M | $7.3M | $80K | +1% |
| Operating cash sources | $26.1M | $21.6M | $4.5M | +21% |
| Share-based compensation | $4.3M | $3.2M | $1.0M | +32% |
| Working capital & other | $2.6M | −$1.6M | $4.2M | — |
| Cash used in operations | $19.3M | $20.0M | −$709K | -4% |
| Net loss absorbed | $26.1M | $21.6M | $4.5M | +21% |
Questions
How much did BioAge Labs's revenue grow year over year in Q2 2026?
BioAge Labs's revenue rose $39K (+2%) from $2.4M in Q2 2025 to $2.5M in Q2 2026.